$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000088398421000005 Filed on February 26, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q3
Revenue	$320.5M	$315.5M	$307.5M
YoY Change	1.56%	-7.3%	-6.02%
Cost Of Revenue	$200.6M	$201.4M	$188.9M
YoY Change	-0.4%	-2.09%	-1.9%
Gross Profit	$119.9M	$114.1M	$118.6M
YoY Change	5.02%	-15.23%	-11.91%
Gross Profit Margin	37.41%	36.17%	38.56%
Selling, General & Admin	$73.40M	$70.60M	$65.88M
YoY Change	3.97%	-7.71%	-14.04%
% of Gross Profit	61.23%	61.85%	55.57%
Research & Development	$11.80M	$12.60M	$12.00M
YoY Change	-6.35%	-6.67%	-8.94%
% of Gross Profit	9.84%	11.04%	10.12%
Depreciation & Amortization	$21.60M	$19.90M	$14.80M
YoY Change	8.54%	1.53%	-1.99%
% of Gross Profit	18.02%	17.43%	12.48%
Operating Expenses	$87.30M	$83.20M	$85.65M
YoY Change	4.93%	-7.56%	-35.27%
Operating Profit	$32.57M	$30.94M	$32.90M
YoY Change	5.28%	-30.69%	1359.58%
Interest Expense	-$700.0K	$1.600M	$139.0K
YoY Change	-143.75%	-111.43%	-50.88%
% of Operating Profit	-2.15%	5.17%	0.42%
Other Income/Expense, Net	$300.0K	$1.500M	-$10.00K
YoY Change	-80.0%	-85.85%	-98.13%
Pretax Income	$30.10M	$20.90M	$32.75M
YoY Change	44.02%	-267.2%	2179.05%
Income Tax	$4.000M	$300.0K	$6.187M
% Of Pretax Income	13.29%	1.44%	18.89%
Net Earnings	$26.14M	$20.64M	$26.56M
YoY Change	26.65%	-380.64%	12029.22%
Net Earnings / Revenue	8.16%	6.54%	8.64%
Basic Earnings Per Share	$1.24	$1.00	$1.29
Diluted Earnings Per Share	$1.21	$0.96	$1.24
COMMON SHARES
Basic Shares Outstanding	20.98M shares	20.67M shares	20.67M shares
Diluted Shares Outstanding			21.49M shares

Balance Sheet

Concept	2020 Q4	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$410.8M	$292.6M	$336.8M
YoY Change	40.37%	-23.42%	-5.34%
Cash & Equivalents	$396.1M	$268.7M	$315.9M
Short-Term Investments	$14.69M	$23.97M	$20.85M
Other Short-Term Assets	$1.822M	$1.992M	$3.300M
YoY Change	-8.53%	28.68%	-38.19%
Inventory	$314.9M	$337.6M	$343.7M
Prepaid Expenses
Receivables	$124.1M	$202.2M	$210.4M
Other Receivables	$3.700M	$20.20M	$24.20M
Total Short-Term Assets	$920.8M	$882.2M	$944.5M
YoY Change	4.37%	-4.84%	3.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$466.6M	$456.1M	$444.1M
YoY Change	2.31%	5.42%	4.52%
Goodwill	$33.00M	$31.25M	$11.02M
YoY Change	5.62%	179.1%	-16.52%
Intangibles	$197.2M	$211.4M	$131.6M
YoY Change	-6.71%	58.45%	-0.13%
Long-Term Investments	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$55.48M	$48.98M	$47.52M
YoY Change	13.25%	21.19%	22.8%
Total Long-Term Assets	$842.9M	$810.2M	$693.3M
YoY Change	4.04%	23.06%	9.72%
TOTAL ASSETS
Total Short-Term Assets	$920.8M	$882.2M	$944.5M
Total Long-Term Assets	$842.9M	$810.2M	$693.3M
Total Assets	$1.764B	$1.692B	$1.638B
YoY Change	4.21%	6.75%	5.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$71.86M	$128.6M	$125.4M
YoY Change	-44.13%	6.77%	77.64%
Accrued Expenses	$97.02M	$117.8M	$130.1M
YoY Change	-17.62%	-8.57%	-1.44%
Deferred Revenue	$5.566M	$4.761M	$7.441M
YoY Change	16.91%	24.83%	16.12%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$600.0K	$0.00
YoY Change
Total Short-Term Liabilities	$195.5M	$248.5M	$255.4M
YoY Change	-21.32%	-0.33%	26.12%
LONG-TERM LIABILITIES
Long-Term Debt	$2.400M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$47.84M	$32.82M	$41.30M
YoY Change	45.75%	-54.23%	-49.08%
Total Long-Term Liabilities	$47.84M	$32.82M	$41.30M
YoY Change	45.75%	-54.23%	-49.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$195.5M	$248.5M	$255.4M
Total Long-Term Liabilities	$47.84M	$32.82M	$41.30M
Total Liabilities	$243.3M	$281.3M	$297.4M
YoY Change	-13.5%	-12.56%	4.39%
SHAREHOLDERS EQUITY
Retained Earnings	$808.7M	$721.8M	$701.1M
YoY Change	12.04%	16.28%	11.63%
Common Stock	$695.2M	$671.0M	$661.8M
YoY Change	3.6%	1.68%	1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$39.00K	$157.0K	$0.00
YoY Change	-75.16%	65.26%	-100.0%
Treasury Stock Shares	209.0 shares	850.0 shares	2.000 shares
Shareholders Equity	$1.502B	$1.377B	$1.340B
YoY Change
Total Liabilities & Shareholders Equity	$1.764B	$1.692B	$1.638B
YoY Change	4.21%	6.75%	5.99%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	$26.14M	$20.64M	$26.56M
YoY Change	26.65%	-380.64%	12029.22%
Depreciation, Depletion And Amortization	$21.60M	$19.90M	$14.80M
YoY Change	8.54%	1.53%	-1.99%
Cash From Operating Activities	$78.60M	$48.80M	$50.80M
YoY Change	61.07%	-2.2%	-0.97%
INVESTING ACTIVITIES
Capital Expenditures	-$31.70M	-$26.30M	-$26.90M
YoY Change	20.53%	28.92%	-7.24%
Acquisitions
YoY Change
Other Investing Activities	-$9.200M	-$74.60M	$3.000M
YoY Change	-87.67%	-5838.46%	-118.75%
Cash From Investing Activities	-$40.90M	-$101.0M	-$23.90M
YoY Change	-59.5%	428.8%	-46.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.500M	3.300M	100.0K
YoY Change	36.36%	-3400.0%	-90.0%
NET CHANGE
Cash From Operating Activities	78.60M	48.80M	50.80M
Cash From Investing Activities	-40.90M	-101.0M	-23.90M
Cash From Financing Activities	4.500M	3.300M	100.0K
Net Change In Cash	42.20M	-48.90M	27.00M
YoY Change	-186.3%	-259.28%	269.86%
FREE CASH FLOW
Cash From Operating Activities	$78.60M	$48.80M	$50.80M
Capital Expenditures	-$31.70M	-$26.30M	-$26.90M
Free Cash Flow	$110.3M	$75.10M	$77.70M
YoY Change	46.87%	6.83%	-3.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2020	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2019Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-34634
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0022692
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	951 Calle Amanecer
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2020	dei	City Area Code CityAreaCode	949
CY2020	dei	Local Phone Number LocalPhoneNumber	366-2183
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Security12b Title Security12bTitle	Common stock, par value $0.10 per share
CY2020	dei	Trading Symbol TradingSymbol	ICUI
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	3594086791	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21138567	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	396097000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268670000	USD
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	14687000	USD
CY2019Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	23967000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	410784000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	292637000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	21490000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20219000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	124093000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	202219000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	314928000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	337640000	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	29480000	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	15720000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41492000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33981000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	920777000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	882197000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	466628000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456085000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46571000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34465000	USD
CY2020Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	12974000	USD
CY2019Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	33001000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	31245000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	197231000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	211408000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31034000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	27998000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55475000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48984000	USD
CY2020Q4	us-gaap	Assets Assets	1763691000	USD
CY2019Q4	us-gaap	Assets Assets	1692382000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	71864000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128629000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97021000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	117776000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	303000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2063000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	26300000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	195488000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	248468000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	17300000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	47835000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	32820000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1663000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2091000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	16440000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	14459000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2019Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21058000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21058000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20743000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20742000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2106000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2074000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	693068000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	668947000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	209	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	850	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	39000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	157000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	808652000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	721782000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1522000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15402000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1502265000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1377244000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1763691000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1692382000	USD
CY2020	us-gaap	Revenues Revenues	1271004000	USD
CY2019	us-gaap	Revenues Revenues	1266208000	USD
CY2018	us-gaap	Revenues Revenues	1400040000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	809507000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	794344000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	830012000	USD
CY2020	us-gaap	Gross Profit GrossProfit	461497000	USD
CY2019	us-gaap	Gross Profit GrossProfit	471864000	USD
CY2018	us-gaap	Gross Profit GrossProfit	570028000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	283953000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	276982000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	320002000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42948000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48611000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52867000	USD
CY2020	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	28409000	USD
CY2019	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	80574000	USD
CY2018	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	105390000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	9000000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-47400000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	20400000	USD
CY2020	icui	Contractsettlements Contractsettlements	-975000	USD
CY2019	icui	Contractsettlements Contractsettlements	5737000	USD
CY2018	icui	Contractsettlements Contractsettlements	41613000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	363335000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	364504000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	540272000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	98162000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	107360000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	29756000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1753000	USD
CY2019	us-gaap	Interest Expense InterestExpense	549000	USD
CY2018	us-gaap	Interest Expense InterestExpense	709000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1085000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7896000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6673000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	97494000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	114707000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22374000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10624000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13672000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6419000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	86870000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	101035000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	28793000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.16
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.90
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.41
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.02
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.69
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20907000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20629000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20394000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21591000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21545000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21601000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	86870000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	101035000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	28793000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	285000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	392000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	317000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	904000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1242000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1003000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	12929000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	372000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3104000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-47000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	71000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-115000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13880000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1543000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1986000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	100750000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	102578000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26807000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1198254000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14275000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6252000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24241000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1986000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	28793000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1263655000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7732000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18639000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21918000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1543000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	101035000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1377244000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13193000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12876000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23954000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	13880000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	86870000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1502265000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	86870000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	101035000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	28793000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85631000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76916000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74735000	USD
CY2020	icui	Operatingleaserightofuseassetamortization Operatingleaserightofuseassetamortization	9216000	USD
CY2019	icui	Operatingleaserightofuseassetamortization Operatingleaserightofuseassetamortization	8294000	USD
CY2018	icui	Operatingleaserightofuseassetamortization Operatingleaserightofuseassetamortization	0	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7137000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14882000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	781000	USD
CY2020	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-1576000	USD
CY2019	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-134000	USD
CY2018	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	5353000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	23954000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	21918000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	24241000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1789000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12872000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8867000	USD
CY2020	icui	Productrationalization Productrationalization	0	USD
CY2019	icui	Productrationalization Productrationalization	0	USD
CY2018	icui	Productrationalization Productrationalization	12696000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5000000	USD
CY2020	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	231000	USD
CY2019	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	135000	USD
CY2018	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	342000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	288000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	288000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	288000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2019	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2018	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	269000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	9000000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-47400000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	20400000	USD
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2626000	USD
CY2019	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	USD
CY2018	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	USD
CY2020	icui	Sparepartsusage Sparepartsusage	11191000	USD
CY2019	icui	Sparepartsusage Sparepartsusage	24301000	USD
CY2018	icui	Sparepartsusage Sparepartsusage	7310000	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6939000	USD
CY2019	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	447000	USD
CY2018	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3856000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-78049000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23684000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	76742000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19196000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24997000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21770000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4311000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8588000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3719000	USD
CY2020	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0	USD
CY2019	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0	USD
CY2018	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-97443000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16069000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	29837000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9086000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46415000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2697000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23270000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29379000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-43689000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29553000	USD
CY2020	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-18037000	USD
CY2019	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	4680000	USD
CY2018	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-19997000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	222752000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	101918000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	160215000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92005000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97312000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92720000	USD
CY2020	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	6176000	USD
CY2019	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	33000	USD
CY2018	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	765000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	0	USD
CY2019	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	0	USD
CY2018	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	13000000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8385000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8728000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8059000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	76133000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1300000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32825000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	26040000	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	30496000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28900000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	41292000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15440000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98139000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-166888000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-103370000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	12598000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1753000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	549000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	709000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2211000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13912000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	26522000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10907000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8023000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2854000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-234000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-10159000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127427000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-76111000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	54709000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268670000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	344781000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	290072000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	396097000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268670000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	344781000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	31628000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	9675000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	150000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	150000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13193000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7732000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14275000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	357000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12876000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18639000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6252000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40000	USD
CY2019	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	91019000	USD
CY2019	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	76133000	USD
CY2019Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	17300000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20026000	USD
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	17612000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020	us-gaap	Use Of Estimates UseOfEstimates	Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	126499000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	119709000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	33053000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	39515000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	155376000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	178416000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	314928000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	337640000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	843096000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	776240000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	376468000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	320155000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	466628000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456085000	USD
CY2020	us-gaap	Depreciation Depreciation	62400000	USD
CY2019	us-gaap	Depreciation Depreciation	59300000	USD
CY2018	us-gaap	Depreciation Depreciation	58100000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	12357000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1300000	USD
CY2018	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-2462000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	11195000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20026000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	24000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	31245000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1756000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	33001000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	267311000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	89443000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	177868000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	286674000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	89443000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	197231000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	263275000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65858000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	197417000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	277266000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65858000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	211408000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23200000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17700000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16600000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	23563000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	22747000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	21724000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	21635000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	17095000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	71104000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	177868000	USD
CY2020Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	27661000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	27661000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-7200000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	700000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-7900000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	600000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	86870000	USD
CY2020	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	10700000	USD
CY2019	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	11400000	USD
CY2018	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	11400000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12083	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10760	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5300	shares
CY2019	us-gaap	Net Income Loss NetIncomeLoss	101035000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	28793000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20907000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20629000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20394000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	684000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	916000	shares
CY2018	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1207000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21591000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21545000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21601000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.16
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.90
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.41
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.02
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.69
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2020	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	Recently Issued Accounting Standards In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. The impact of this ASU on our contracts has not been material.
CY2020	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	28400000	USD
CY2019	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	80600000	USD
CY2018	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	105400000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	7900000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	8400000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	4500000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	1416000	USD
CY2019	us-gaap	Restructuring Costs RestructuringCosts	8375000	USD
CY2019	us-gaap	Revenues Revenues	1266208000	USD
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	4242000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	5549000	USD
CY2020	us-gaap	Restructuring Costs RestructuringCosts	7929000	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	10361000	USD
CY2020	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	304000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	3421000	USD
CY2020	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	20500000	USD
CY2019	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	72200000	USD
CY2018	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	100900000	USD
CY2019	icui	Supplychainrestructuringcosts Supplychainrestructuringcosts	22100000	USD
CY2019	icui	Cleanupcosts Cleanupcosts	12700000	USD
CY2018	icui	Common Shares Soldby Pfizer CommonSharesSoldbyPfizer	2500000	shares
CY2018	us-gaap	Payments For Fees PaymentsForFees	8000000.0	USD
CY2020	us-gaap	Revenues Revenues	1271004000	USD
CY2020	icui	Percentageofrevenue Percentageofrevenue	1
CY2019	icui	Percentageofrevenue Percentageofrevenue	1
CY2018	us-gaap	Revenues Revenues	1400040000	USD
CY2018	icui	Percentageofrevenue Percentageofrevenue	1
CY2020	us-gaap	Revenues Revenues	1271004000	USD
CY2019	us-gaap	Revenues Revenues	1266208000	USD
CY2018	us-gaap	Revenues Revenues	1400040000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4282000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4855000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6430000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4700000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P15Y
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	11284000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	10011000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	91000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	383000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	263000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	322000	USD
CY2020	us-gaap	Lease Cost LeaseCost	12021000	USD
CY2019	us-gaap	Lease Cost LeaseCost	10333000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	10185000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	10344000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	91000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20847000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3230000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3062000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46571000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34465000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28896000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	49759000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36258000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0502
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0557
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2915000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	554000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2388000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2942000	USD
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0427
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10981000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	666000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	666000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9956000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	666000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8767000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	666000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8279000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	338000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5002000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	207000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	15289000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	805000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	58274000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3348000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8515000	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	406000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	49759000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2942000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	23954000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	21918000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	24241000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5564000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4840000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5706000	USD
CY2020	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	1203000	USD
CY2019	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	680000	USD
CY2018	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	2199000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	26300000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M24D
CY2020Q4	us-gaap	Share Price SharePrice	214.49
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	32915000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	22976000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	51105000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13193000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7732000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14275000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5179000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	9653000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	12617000	USD
CY2019Q4	icui	Deferredtaxcharge Deferredtaxcharge	1266000	USD
CY2020Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	3555000	USD
CY2020Q4	icui	Espp Original Issuance ESPPOriginalIssuance	750000	shares
CY2020Q4	icui	Espp Annual Issuance Increase Limit ESPPAnnualIssuanceIncreaseLimit	300000	shares
CY2020Q4	icui	Shares Available In Employee Stock Purchase Plan SharesAvailableInEmployeeStockPurchasePlan	133487	shares
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	790000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	916000	USD
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	743000	USD
CY2020Q4	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	-3600000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27000000	USD
CY2018	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	20400000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	47400000	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	17300000	USD
CY2019	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-47400000	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	17300000	USD
CY2020	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	9000000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	26300000	USD
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	14687000	USD
CY2020Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	12974000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	31216000	USD
CY2019Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	23967000	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	26333000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	14964000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	13778000	USD
CY2020Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	6402000	USD
CY2019Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	3332000	USD
CY2020Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	6178000	USD
CY2019Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	5450000	USD
CY2020Q4	icui	Prepaidothertaxes Prepaidothertaxes	3676000	USD
CY2019Q4	icui	Prepaidothertaxes Prepaidothertaxes	4422000	USD
CY2020Q4	icui	Deferredtaxcharge Deferredtaxcharge	3542000	USD
CY2019Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	2366000	USD
CY2020Q4	us-gaap	Deposit Assets DepositAssets	1353000	USD
CY2019Q4	us-gaap	Deposit Assets DepositAssets	1375000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1822000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1992000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41492000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33981000	USD
CY2020Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	25786000	USD
CY2019Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	21116000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	27023000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	15221000	USD
CY2020Q4	icui	Accruedsupplychainrestructuring Accruedsupplychainrestructuring	0	USD
CY2019Q4	icui	Accruedsupplychainrestructuring Accruedsupplychainrestructuring	23119000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1273000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	4782000	USD
CY2020Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	0	USD
CY2019Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	2096000	USD
CY2020Q4	icui	Accruedlegalfees Accruedlegalfees	900000	USD
CY2019Q4	icui	Accruedlegalfees Accruedlegalfees	826000	USD
CY2020Q4	icui	Accruedsalestaxes Accruedsalestaxes	2146000	USD
CY2019Q4	icui	Accruedsalestaxes Accruedsalestaxes	2615000	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1027000	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	782000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5566000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4761000	USD
CY2020Q4	icui	Accruedothertaxes Accruedothertaxes	3540000	USD
CY2019Q4	icui	Accruedothertaxes Accruedothertaxes	4054000	USD
CY2020Q4	icui	Outsidesalescommissions Outsidesalescommissions	5300000	USD
CY2019Q4	icui	Outsidesalescommissions Outsidesalescommissions	3942000	USD
CY2020Q4	icui	Accruedfreight Accruedfreight	6784000	USD
CY2019Q4	icui	Accruedfreight Accruedfreight	11238000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3421000	USD
CY2020Q4	icui	Unfavorablecontractliability St UnfavorablecontractliabilityST	0	USD
CY2019Q4	icui	Unfavorablecontractliability St UnfavorablecontractliabilityST	1935000	USD
CY2019Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	5459000	USD
CY2020Q4	icui	Contractsettlement St ContractsettlementST	0	USD
CY2019Q4	icui	Contractsettlement St ContractsettlementST	1667000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5515000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6801000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97021000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	117776000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	41019000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	28896000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2388000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	USD
CY2020Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	337000	USD
CY2019Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	472000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	864000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	94000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	1183000	USD
CY2019Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	1131000	USD
CY2020Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1462000	USD
CY2019Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1642000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	582000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	585000	USD
CY2020Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	47835000	USD
CY2019Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	32820000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	150000000	USD
CY2020	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-11-08
CY2020Q4	icui	Lineof Credit Accordion LineofCreditAccordion	100000000	USD
CY2020Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Gross DebtIssuanceCostsLineOfCreditArrangementsGross	1400000	USD
CY2020	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	In general, borrowing under the Credit Facility (other than Swingline loans) bears interest, at our option, based on the Base Rate plus applicable margin or the London Interbank Offered Rate ("LIBOR") rate plus applicable margin, as defined below:
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41194000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	32849000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8600000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	56300000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	81858000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30974000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	97494000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	114707000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22374000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6032000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6851000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	492000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2422000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2532000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1865000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7290000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7994000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9136000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15744000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17377000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11493000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5319000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6720000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9118000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1850000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-325000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3072000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	2049000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3340000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-5722000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5120000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3705000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17912000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10624000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13672000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6419000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3200000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20474000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	24088000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4699000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2099000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1269000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	927000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3269000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.034
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2896000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.025
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	4961000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.222
CY2020	icui	Gilt Itaxexpense GILTItaxexpense	-2555000	USD
CY2020	icui	Gilt Itaxexpensepercent GILTItaxexpensepercent	-0.026
CY2019	icui	Gilt Itaxexpense GILTItaxexpense	6118000	USD
CY2019	icui	Gilt Itaxexpensepercent GILTItaxexpensepercent	0.053
CY2018	icui	Gilt Itaxexpense GILTItaxexpense	2363000	USD
CY2018	icui	Gilt Itaxexpensepercent GILTItaxexpensepercent	0.106
CY2020	icui	Effective Tax Rate Reconciliation Ip Migration Percent EffectiveTaxRateReconciliationIPMigrationPercent	0
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5939000	USD
CY2018	icui	Effective Income Tax Rate R Econciliation Tax Reform EffectiveIncomeTaxRateREconciliationTaxReform	0.037
CY2020	icui	Effective Income Tax Rate Reconciliation Ip Migration EffectiveIncomeTaxRateReconciliationIPMigration	0	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3888000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.040
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.052
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2944000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.132
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4686000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.048
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-8446000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.074
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-11040000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.493
CY2020	icui	Taxreform Taxreform	0	USD
CY2020	icui	Effective Income Tax Rate R Econciliation Tax Reform EffectiveIncomeTaxRateREconciliationTaxReform	0
CY2019	icui	Taxreform Taxreform	0	USD
CY2019	icui	Effective Income Tax Rate R Econciliation Tax Reform EffectiveIncomeTaxRateREconciliationTaxReform	0
CY2018	icui	Taxreform Taxreform	826000	USD
CY2019	icui	Effective Income Tax Rate Reconciliation Ip Migration EffectiveIncomeTaxRateReconciliationIPMigration	-2118000	USD
CY2019	icui	Effective Tax Rate Reconciliation Ip Migration Percent EffectiveTaxRateReconciliationIPMigrationPercent	-0.018
CY2018	icui	Effective Income Tax Rate Reconciliation Ip Migration EffectiveIncomeTaxRateReconciliationIPMigration	3252000	USD
CY2018	icui	Effective Tax Rate Reconciliation Ip Migration Percent EffectiveTaxRateReconciliationIPMigrationPercent	0.145
CY2020	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	-1566000	USD
CY2020	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0.016
CY2019	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0	USD
CY2019	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0
CY2018	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0	USD
CY2018	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0
CY2020	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	1079000	USD
CY2020	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	0.011
CY2019	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	203000	USD
CY2019	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	0.002
CY2018	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	456000	USD
CY2018	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	0.020
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-196000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1393000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.012
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10624000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.109
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13672000	USD
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.119
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6419000	USD
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.287
CY2020Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	68666000	USD
CY2019Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	67961000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	29371000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	25907000	USD
CY2020Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	16700000	USD
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	8000000.0	USD
CY2020	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.37
CY2019	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	7800000	USD
CY2019	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.36
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	97800000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18400000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15027000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10824000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6527000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	502000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	138000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2987000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4231000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4536000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	15000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	146000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	58000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	163000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	93000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18443000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15027000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10824000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	843096000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	776240000	USD
CY2020Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000.0	USD
CY2018	icui	Icu Medical Msa Revenue ICUMedicalMSARevenue	81000000.0	USD
CY2020Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	100000000.0	USD
CY2020	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	67041	shares
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12900000	USD
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	209	shares
CY2019	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	80186	shares
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18600000	USD
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	850	shares
CY2018	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	26307	shares
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6300000	USD
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	408	shares
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14959000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1421000	USD
CY2018	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-565000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1986000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16945000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2239000	USD
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-696000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1543000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15402000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	14481000	USD
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-601000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13880000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1522000	USD
CY2018	icui	Pfizer Msa Product Costs PfizerMSAProductCosts	78200000	USD
CY2020Q1	us-gaap	Revenues Revenues	328607000	USD
CY2020Q2	us-gaap	Revenues Revenues	303379000	USD
CY2020Q3	us-gaap	Revenues Revenues	318567000	USD
CY2020Q4	us-gaap	Revenues Revenues	320451000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	121415000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	106284000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	113924000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	119874000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	16834000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	18908000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	24986000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	26142000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.24
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.21
CY2019Q1	us-gaap	Revenues Revenues	330932000	USD
CY2019Q2	us-gaap	Revenues Revenues	312282000	USD
CY2019Q3	us-gaap	Revenues Revenues	307471000	USD
CY2019Q4	us-gaap	Revenues Revenues	315523000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	135303000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	103869000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	118552000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	114140000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	30998000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	22833000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	26563000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	20641000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.51
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.44
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.24
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96

Files In Submission

Name	View Source	Status
0000883984-21-000005-index-headers.html	Edgar Link	pending
0000883984-21-000005-index.html	Edgar Link	pending
0000883984-21-000005.txt	Edgar Link	pending
0000883984-21-000005-xbrl.zip	Edgar Link	pending
exhibit105executiveofficer.htm	Edgar Link	pending
exhibit106non-employeedire.htm	Edgar Link	pending
exhibit21subsidiariesofreg.htm	Edgar Link	pending
exhibit231consentofdeloitt.htm	Edgar Link	pending
exhibit311123120.htm	Edgar Link	pending
exhibit312123120.htm	Edgar Link	pending
exhibit32123120.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20201231.htm	Edgar Link	pending
icui-20201231.xsd	Edgar Link	pending
icui-20201231_cal.xml	Edgar Link	unprocessable
icui-20201231_def.xml	Edgar Link	unprocessable
icui-20201231_htm.xml	Edgar Link	completed
icui-20201231_lab.xml	Edgar Link	unprocessable
icui-20201231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2020 Q4 Form 10-K Financial Statement

#000088398421000005 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2020 Q4 Form 10-K Financial Statement

#000088398421000005 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui